1. Home
  2. TWO vs CRVS Comparison

TWO vs CRVS Comparison

Compare TWO & CRVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Two Harbors Investment Corp

TWO

Two Harbors Investment Corp

HOLD

Current Price

$12.00

Market Cap

1.3B

Sector

Real Estate

ML Signal

HOLD

Logo Corvus Pharmaceuticals Inc.

CRVS

Corvus Pharmaceuticals Inc.

HOLD

Current Price

$14.48

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TWO
CRVS
Founded
2009
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.1B
IPO Year
2009
2016

Fundamental Metrics

Financial Performance
Metric
TWO
CRVS
Price
$12.00
$14.48
Analyst Decision
Hold
Strong Buy
Analyst Count
7
6
Target Price
$12.56
$30.17
AVG Volume (30 Days)
3.4M
834.7K
Earning Date
04-28-2026
05-07-2026
Dividend Yield
11.77%
N/A
EPS Growth
N/A
48.04
EPS
0.18
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$66.61
N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.84
$4.70
52 Week High
$14.17
$26.95

Technical Indicators

Market Signals
Indicator
TWO
CRVS
Relative Strength Index (RSI) 37.92 56.54
Support Level $10.89 $14.24
Resistance Level $12.14 $16.66
Average True Range (ATR) 0.04 0.69
MACD -0.00 0.04
Stochastic Oscillator 6.67 96.61

Price Performance

Historical Comparison
TWO
CRVS

About TWO Two Harbors Investment Corp

Two Harbors Investment Corp is a real estate investment trust focused on investing in, financing, and managing residential mortgage-backed securities, residential mortgage loans, mortgage servicing rights, and commercial real estate. The majority of its investment portfolio is split between agency RMBS purchased from government-sponsored enterprises and nonagency RMBS. The company derives revenues mainly from its MSR and Agency RMBS portfolio, including servicing fee income, float income, and interest income, as well as mortgage loan origination activities established to support the MSR portfolio. Its investment portfolio is subject to market risks, mainly interest rate, basis, and prepayment risk. The majority of income is generated by available-for-sale securities.

About CRVS Corvus Pharmaceuticals Inc.

Corvus Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. It believes its proprietary product candidates have broad potential to address immune mediated diseases, inflammatory diseases and cancers. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The company operates in one primary business activity and operate as one reportable segment.

Share on Social Networks: